Skip to main content

8 Result(s)

within O Hequet Remove this filter

and

  1. No Access

    Article

    Listeriosis after fludarabine treatment for chronic lymphocytic leukemia

    The authors report a case of Listeria monocytogenes septicemia in a patient with advanced CLL after a single course of fludarabine, without any other immunosuppressive therapy e.g. corticosteroids. The immunosupp...

    O. Hequet, J. P. de Jaureguiberry, D. Jaubert, O. Gisserot… in Hematology and Cell Therapy (1997)

  2. No Access

    Article

    A prospective study of intensive induction therapy with high-dose consolidation in patients with aggressive non-Hodgkin's lymphoma and two or three adverse prognostic factors

    Patients with nhl and two or three factors of the international prognostic index (ipi) have a poor prognosis. we performed a prospective trial of intensive induction therapy followed with high-dose consolidati...

    C Dumontet, C Thieblemont, D Espinouse, F Bouafia, O Hequet, G Salles… in Leukemia (2000)

  3. No Access

    Article

    Epileptic seizures after autologous peripheral blood progenitor infusion in a patient treated with high-dose chemotherapy for myeloma

    Bone Marrow Transplantation (2002) 29, 544. doi:10.1038/sj.bmt.1703383

    O Hequet, C Dumontet, A El Jaafari-Corbin, G Salles… in Bone Marrow Transplantation (2002)

  4. No Access

    Article

    Multifocal progressive leukoencephalopathy occurring after refractory anemia and multiple infectious disorders consecutive to severe lymphopenia

    Progressive multifocal leukoencephalopathy (PML) is related to central nervous system infection with JC virus (JCV). This leukoencephalopathy occurs in immunocompromised patients such as those with acquired i...

    O. Hequet, G. Salles, D. Espinousse, C. Dumontet, F. Bouafia… in Annals of Hematology (2002)

  5. No Access

    Article

    Amifostine reduces mucosal damage after high-dose melphalan conditioning and autologous peripheral blood progenitor cell transplantation for patients with multiple myeloma

    High-dose melphalan (HDM) has been adopted as standard therapy in the treatment of multiple myeloma. This treatment is associated with non-selective cytotoxicity, causing oral mucositis as the major non-hemato...

    C Thieblemont, C Dumontet, H Saad, N Roch, F Bouafia… in Bone Marrow Transplantation (2002)

  6. No Access

    Article

    Autoimmune thrombocytopenic purpura after autologous stem cell transplantation

    The pathogenesis of thrombocytopenia occurring after autologous stem cell transplantation (ASCT) remains unclear. Six cases of classical peripheral thrombocytopenia that developed after ASCT for non-Hodgkin's ...

    O Hequet, G Salles, N Ketterer, D Espinouse, C Dumontet… in Bone Marrow Transplantation (2003)

  7. No Access

    Article

    Allogeneic donor bone marrow cells recovery and infusion after allogeneic face transplantation from the same donor

    O Hequet, J-P Bourgeot, M Michallet, E Morelon… in Bone Marrow Transplantation (2008)

  8. Article

    Erratum: Allogeneic donor bone marrow cells recovery and infusion after allogeneic face transplantation from the same donor

    Correction to: Bone Marrow Transplantation (2008) 41, 1059–1061; doi:10.1038/bmt.2008.23 The order of authors' names was published incorrectly. The correct author list and affiliations are shown above. We woul...

    O Hequet, E Morelon, J-P Bourgeot, V Dubois, B Devauchelle… in Bone Marrow Transplantation (2008)

    Download PDF (68 KB) View Article